Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD

Nephrology Dialysis Transplantation

Volumn 25, Issue 9, 2010, Pages 3003-3011

  Kovesdy, Csaba P ^a,b   Ureche, Vitalie ^c   Lu, Jun L ^d   Kalantar Zadeh, Kamyar ^e,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CARILION CLINIC   (United States)

^d Salem Research Institute   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

alkaline phosphatase; chronic kidney disease; mortality

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCITRIOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIALYSIS; ENZYME BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; VETERAN;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CALCIUM; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MODELS, STATISTICAL; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; VETERANS;

EID: 77956236574     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq144     Document Type: Article

References (35)

1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
2. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780
3. Kovesdy CP, Kalantar-Zadeh K. Bone and mineral disorders in predialysis CKD. Int Urol Nephrol 2008; 40: 427-440
4. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528
5. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916
6. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 2008; 73: 1296-1302
7. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MW, Larsson L. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001; 60: 257-265
8. Torres PU. Bone alkaline phosphatase isoforms in chronic renal failure. Kidney Int 2002; 61: 1178-1179
9. Regidor DL, Kovesdy CP, Mehrotra R et al. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008; 19: 2193-2203
10. Eknoyan G, Levin A, Levin N. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-201
11. Lomashvili KA, Garg P, Narisawa S, Millan JL, ONeill WC. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 2008; 73: 1024-1030
12. ONeill WC. Pyrophosphate, alkaline phosphatase, and vascular calcification. Circ Res 2006; 99: e2
13. Schoppet M, Shanahan CM. Role for alkaline phosphatase as an inducer of vascular calcification in renal failure? Kidney Int 2008; 73: 989-991
14. Shantouf R, Kovesdy CP, Kim Y et al. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1106-1114
15. Tonelli M, Curhan G, Pfeffer M et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 2009; 120: 1784-1792
16. Fahrleitner-Pammer A, Herberth J, Browning SR et al. Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 2008; 23: 1850-1858
17. Beddhu S, Ma X, Baird B, Cheung AK, Greene T. Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1805-1810
18. Kovesdy CP, Trivedi BK, Anderson JE. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 2006; 13: 183-188
19. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 2006; 21: 1257-1262
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
21. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
22. Heemskerk S, Masereeuw R, Moesker O et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 2009; 37: 417-423 e1
23. Thadhani R, Tonelli M. Cohort studies: marching forward. Clin J Am Soc Nephrol 2006; 1: 1117-1123
24. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 76: S1-S130
25. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, ONeill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401
26. Schibler D, Russell RG, Fleisch H. Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 1968; 35: 363-372
27. Narisawa S, Harmey D, Yadav MC, ONeill WC, Hoylaerts MF, Millan JL. Novel inhibitors of alkaline phosphatase suppress vascular smooth muscle cell calcification. J Bone Miner Res 2007; 22: 1700-1710
28. Stehman-Breen CO, Sherrard D, Walker A, Sadler R, Alem A, Lindberg J. Racial differences in bone mineral density and bone loss among end-stage renal disease patients. Am J Kidney Dis 1999; 33: 941-946
29. Lips P, Duong T, Oleksik A et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212-1221
30. Sahota O, Masud T, San P, Hosking DJ. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf) 1999; 51: 217-221
31. Thomas MK, Lloyd-Jones DM, Thadhani RI et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783
32. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013
33. van Veen SQ, van Vliet AK, Wulferink M, Brands R, Boermeester MA, van Gulik TM. Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice. Infect Immun 2005; 73: 4309-4314
34. Verweij WR, Bentala H, Huizinga-vanderVlag A et al. Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice. Shock 2004; 22: 174-179
35. Koyama I, Matsunaga T, Harada T, Hokari S, Komoda T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin Biochem 2002; 35: 455-461